Ben Capps

Benjamin J. Capps

Associate

Ben Capps is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He works with companies at all stages of development on corporate formation, corporate governance, venture capital financings, mergers and acquisitions, public offerings, and securities law matters.

During law school, Ben worked as a law clerk in Wilson Sonsini's San Diego office and with a business law firm in Santa Monica.

Experience

During law school, Ben worked as a law clerk in Wilson Sonsini's San Diego office and with a business law firm in Santa Monica.

Education

J.D., UCLA School of Law, 2015Submissions Editor, UCLA Entertainment Law Review
B.A., English and History, Wake Forest University, 2012

Admissions

State Bar of California

Credentials

Education

J.D., UCLA School of Law, 2015Submissions Editor, UCLA Entertainment Law Review
B.A., English and History, Wake Forest University, 2012

Admissions

State Bar of California

Recent Insights

Client Highlights

On July 15, 2024, LENZ Therapeutics (LENZ), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve near vision in people with presbyopia, announced that it has entered into a stock purchase agreement with Ridgeback Capital for a $30 million private investment in public equity (PIPE) common stock financing. Wilson Sonsini Goodrich & Rosati advised LENZ on the transaction.

Learn More

Client Highlights

On March 21, 2024, LENZ Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people with presbyopia, announced the completion of its previously announced merger with Graphite Bio, Inc. The new combined company will operate under the name LENZ Therapeutics, Inc. and will commence trading on Nasdaq under the ticker symbol “LENZ” on March 22, 2024. Wilson Sonsini Goodrich & Rosati advised LENZ Therapeutics on the transaction.

Learn More